Merck Serono gets Japanese nod for easypod

Merck Serono, a division of Merck KgaA Darmstadt, Germany, announced that the Japanese health authorities, the Pharmaceutical and Medical Devices Agency (PMDA), have granted a marketing authorization for easypod in Japan. Easypod was developed for exclusive use with cartridges of Saizen (somatropin), Merck Serono's human recombinant growth hormone for the treatment of growth hormone deficiency.

Easypod is an innovative electronic auto injection device designed to improve ease of usage, reliability and convenience for patients who need daily subcutaneous injections of Saizen. It allows patients to self-inject in just three simple key steps. Additionally, a built-in dose memory automatically records the number of doses administered, allowing physicians and caregivers to accurately monitor patient adherence to therapy.